Hemofiltration in ex vivo lung perfusion-a study in experimentally induced pulmonary edema

J Thorac Cardiovasc Surg. 2016 Feb;151(2):570-5.e1. doi: 10.1016/j.jtcvs.2015.06.046. Epub 2015 Jun 29.

Abstract

Objectives: Ex vivo lung perfusion (EVLP) can potentially reduce pulmonary edema. In a pig model with induced pulmonary edema, we evaluated the effect of hemofiltration (HF) during EVLP on lung function, perfusate oncotic pressure, and lung weight.

Methods: In anesthetized pigs (n = 14), pulmonary edema was induced by a balloon in the left atrium, combined with crystalloid infusion (20 mL/kg), for 2 hours. The lungs were harvested, stored cold for 2 hours, and randomized to EVLP, with or without a hemofilter (HF and noHF groups, respectively, n = 7 for each). EVLP was performed with cellular perfusate at a hematocrit of 10% to 15%. Oncotic pressure, lung performance, and weight were measured before and after 180 minutes of EVLP reconditioning with or without HF.

Results: After in vivo induction of edema, arterial oxygen tension (Pao2)/inspired oxygen fraction (Fio2), and compliance decreased by 63% and 16%, respectively. Pao2/Fio2 was considerably improved at first evaluation ex vivo in both groups. HF increased oncotic pressure by 43% and decreased lung weight by 15%. The effects were negligible in the noHF group. Compliance decreased in both groups during reconditioning, although less so in the HF group (P < .05). Pao2/Fio2, shunt fraction, and oxygen saturation remained unchanged in both groups. Pulmonary flow index decreased in both groups, and was partially reversed by nitroglycerin. Dorsal atelectatic consolidations were seen in both groups.

Conclusions: In this lung-edema model, EVLP reconditioning with hyperoncotic solution did not affect the degree of lung edema. HF during EVLP increased perfusate oncotic pressure, decreased lung weight with beneficial effects on compliance, but did not improve lung oxygenation capacity.

Keywords: ex vivo lung perfusion; hemofiltration; lung edema; lung reconditioning.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Feasibility Studies
  • Hemofiltration*
  • In Vitro Techniques
  • Lung / blood supply
  • Lung / drug effects
  • Lung / pathology
  • Lung / physiopathology*
  • Lung Compliance
  • Models, Animal
  • Nitroglycerin / pharmacology
  • Organ Size
  • Perfusion / methods*
  • Pressure
  • Pulmonary Circulation
  • Pulmonary Edema / pathology
  • Pulmonary Edema / physiopathology
  • Pulmonary Edema / therapy*
  • Respiration
  • Swine
  • Time Factors
  • Vasodilator Agents / pharmacology

Substances

  • Vasodilator Agents
  • Nitroglycerin